title: Remission of Philadelphia chromosome-positive central nervous system leukemia after dasatinib therapy.
authors.forename: Ahmed
authors.initials: A
authors.lastname: Abdelhalim
authors.forename: Maurice
authors.initials: M
authors.lastname: Barcos
authors.forename: Annemarie W
authors.initials: AW
authors.lastname: Block
authors.forename: Sheila N J
authors.initials: SN
authors.lastname: Sait
authors.forename: Petr
authors.initials: P
authors.lastname: Starostik
authors.forename: Meir
authors.initials: M
authors.lastname: Wetzler
authors.forename: Eunice S
authors.initials: ES
authors.lastname: Wang
mesh_terms: D001921:Brain / Q000473:pathology; D016543:Central Nervous System Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000401:mortality / Q000473:pathology*; D000069439:Dasatinib; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D020128:Inhibitory Concentration 50; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000235:genetics / Q000401:mortality / Q000473:pathology*; D008279:Magnetic Resonance Imaging / Q000379:methods; D008297:Male; D008875:Middle Aged; D011743:Pyrimidines / Q000627:therapeutic use*; D012074:Remission Induction; D013844:Thiazoles / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D011743:Pyrimidines; D013844:Thiazoles; D000069439:Dasatinib